Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
943 of 1,108 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,448 total, page 2 of 29
Safe Spaces 4 Sexual Health
NCT07133555
High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment
NCT05954559
Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH
NCT07166172
Impact of the Corrie Lipids Digital Health Program on Lipid Optimization
NCT07478887
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure
NCT06364644
Sleep TO Prevent Post-surgical Pain
NCT06976138
Mobile Health Technology-Enabled AFib Management
NCT06500988
The Role of Music in Enhancing Attention During Visual Field Exams for Pediatric Glaucoma Patients
NCT06971588
Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels
NCT06934200
Groceries Plus Multi-Component Lifestyle Intervention for Adults With Hypertension and Type 2 Diabetes
NCT06921356
Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder
NCT06704594
Leveraging Electronic Health Record Tools to Improve the Evidence-Based Treatment of Children Hospitalized With Bronchiolitis
NCT06932341
Anesthetic Optimization in Pediatric LeFort Surgeries
NCT05260320
External Post-Operative Skull Prosthesis to Prevent Sunken Flap Syndrome in Craniectomy Patients
NCT06899711
Psilocybin Brain Stimulation and Imaging Pilot Study
NCT06835699
Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults
NCT06919926
Scents of Progress: Leveraging a Novel Device for Olfactory Training in Older Adults
NCT06733636
320-detector Computed Tomography to Assess Myocardial Extracellular Volume Fraction in Patients With Atrial Fibrillation Before AF Ablation.
NCT06308094
Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
NCT06656702
Autologous Bone Marrow Aspirate Treatment for Early-Stage Osteonecrosis
NCT06123481
Telerehabilitation for Patients With Chronic Low Back Pain (TeleBACK Clinical Trial)
NCT06821607
Myofascial Dysfunction in Post Stroke Shoulder Pain
NCT06718413
Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia
NCT06604520
Effect of Cannabis on E-Cigarette Use Behavior
NCT06609109
Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings
NCT06151158
The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription.
NCT06536517
Night Owl Metabolism
NCT06507722
Behavioral Pharmacology of Orally Administered THC and D-limonene
NCT06378957
Investigation of Psychedelic Effects in Psychoactive Substances
NCT06772753
Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)
NCT06847685
Improving Health for Patients With Chronic LBP in Rural Communities Through Telerehabilitation
NCT06471920
CAPABLE Transplant
NCT06326905
Effect of Cannabis on Cigarette Use Behavior
NCT06609083
Development of the Couplet Care Bassinet
NCT06533449
Yoga for Back Pain in Adolescent Scoliosis
NCT06242821
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
NCT06525571
Community Engagement Alliance Against Disparities
NCT06607341
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
NCT06299436
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
NCT06273072
Safety for Home Administration of Microdose Psilocybin Use
NCT06450210
Brain and Behavior Influences on Obesity Development From Infancy Through Childhood
NCT06861868
Long Term Outcomes After Vestibular Implantation
NCT06500975
Preliminary Characterization of Commercial Kratom Extract Products
NCT06640569
Strategies to AchieVe Viral Suppression for Youth With HIV
NCT06886971
Brain Volume and Cardiac Function in Heart Failure
NCT06623344
Psilocybin-assisted Treatment for Cannabis Use Disorder
NCT06660381
Accelerated Flap Coverage in Severe Lower Extremity Trauma
NCT06293469
Scrambler Therapy in Chronic Pancreatitis
NCT07174609
Utilizing Pediatric Primary Care Connections to Advance Reproductive Health
NCT07064837
Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT06293040
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Johns Hopkins University: open-pipeline peers nationwide
Peers matched on 1,448 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Johns Hopkins University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,448 trials (± recruiting share)
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Yale University · 1,492 trials · 17% recruiting
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Seattle Children's Hospital · 17% recruiting · 168 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
- Virginia Polytechnic Institute and State University · 17% recruiting · 104 trials
Related
What to do with this Johns Hopkins University page
1,448 registered trials is a research-attention snapshot, not an endorsement of Johns Hopkins University or any single study.
- 250 of Johns Hopkins University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Johns Hopkins University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Johns Hopkins University pipeline card: 1,448 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.